Fed. Circ. Revives Par Pharma's Appetite Drug Patent
The Federal Circuit on Wednesday overturned a lower court's decision that Par Pharmaceutical Inc.'s patent for an appetite stimulant drug for AIDS patients was invalid, ruling that the district court had...To view the full article, register now.
Already a subscriber? Click here to view full article